Nuvectra Corporation Company Profile (NASDAQ:NVTR)

About Nuvectra Corporation (NASDAQ:NVTR)

Nuvectra Corporation logoNuvectra Corporation is a neurostimulation company that focuses on helping physicians to improve the lives of people with chronic neurological conditions. The Company's Algovita Spinal Cord Stimulation (SCS) System (Algovita) is the Company's commercial offering and is Conformite Europeene (CE) marked and the United States Food and Drug Administration (FDA) approved for the treatment of chronic pain of the trunk and/or limbs. Its technology platform also has capabilities under development to support other neurological indications, such as sacral nerve stimulation (SNS) and deep brain stimulation (DBS). In addition, its NeuroNexus Technologies, Inc. (NeuroNexus) subsidiary designs, manufactures and markets neural-interface technologies for the neuroscience clinical research market. Its Virtis is an application of the Company's neurostimulation technology platform and its first product for the SNS market. Its subsidiaries include Algostim, LLC (Algostim) and PelviStim LLC (PelviStim).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Bio Medical Devices
  • Sub-Industry: N/A
  • Symbol: NASDAQ:NVTR
  • CUSIP: N/A
  • Web: www.nuvectramed.com
Capitalization:
  • Market Cap: $149.47 million
  • Outstanding Shares: 10,746,000
Average Prices:
  • 50 Day Moving Avg: $12.89
  • 200 Day Moving Avg: $12.89
  • 52 Week Range: $4.63 - $15.00
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -3.52
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $20.18 million
  • Price / Sales: 7.73
  • Book Value: $6.23 per share
  • Price / Book: 2.33
Profitability:
  • EBITDA: ($43,280,000.00)
  • Net Margins: -232.31%
  • Return on Equity: -56.68%
  • Return on Assets: -42.59%
Debt:
  • Debt-to-Equity Ratio: 0.19%
  • Current Ratio: 3.80%
  • Quick Ratio: 3.50%
Misc:
  • Average Volume: 30,800 shs.
  • Beta: 0.88
  • Short Ratio: 2.87
 

Frequently Asked Questions for Nuvectra Corporation (NASDAQ:NVTR)

What is Nuvectra Corporation's stock symbol?

Nuvectra Corporation trades on the NASDAQ under the ticker symbol "NVTR."

How were Nuvectra Corporation's earnings last quarter?

Nuvectra Corporation (NASDAQ:NVTR) released its quarterly earnings results on Tuesday, August, 8th. The company reported ($1.07) earnings per share for the quarter, topping the consensus estimate of ($1.14) by $0.07. The firm had revenue of $7.20 million for the quarter, compared to analysts' expectations of $5.96 million. Nuvectra Corporation had a negative net margin of 232.31% and a negative return on equity of 56.68%. The business's quarterly revenue was up 188.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted ($0.85) earnings per share. View Nuvectra Corporation's Earnings History.

When will Nuvectra Corporation make its next earnings announcement?

Nuvectra Corporation is scheduled to release their next quarterly earnings announcement on Wednesday, November, 8th 2017. View Earnings Estimates for Nuvectra Corporation.

Where is Nuvectra Corporation's stock going? Where will Nuvectra Corporation's stock price be in 2017?

2 brokers have issued 12-month price targets for Nuvectra Corporation's shares. Their forecasts range from $12.00 to $14.00. On average, they expect Nuvectra Corporation's stock price to reach $13.00 in the next year. View Analyst Ratings for Nuvectra Corporation.

Who are some of Nuvectra Corporation's key competitors?

How do I buy Nuvectra Corporation stock?

Shares of Nuvectra Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Nuvectra Corporation's stock price today?

One share of Nuvectra Corporation stock can currently be purchased for approximately $14.52.


MarketBeat Community Rating for Nuvectra Corporation (NASDAQ NVTR)
Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  77 (Vote Outperform)
Underperform Votes:  60 (Vote Underperform)
Total Votes:  137
MarketBeat's community ratings are surveys of what our community members think about Nuvectra Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Nuvectra Corporation (NASDAQ:NVTR) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating, 1 Buy Rating
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $13.00 (10.47% downside)
Consensus Price Target History for Nuvectra Corporation (NASDAQ:NVTR)
Price Target History for Nuvectra Corporation (NASDAQ:NVTR)
Analysts' Ratings History for Nuvectra Corporation (NASDAQ:NVTR)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/6/2017Piper Jaffray CompaniesReiterated RatingNeutral$14.00HighView Rating Details
5/15/2017B. RileyReiterated RatingBuy$12.00HighView Rating Details
6/3/2016Sterne Agee CRTInitiated CoverageBuy$14.00N/AView Rating Details
(Data available from 10/19/2015 forward)

Earnings

Earnings History for Nuvectra Corporation (NASDAQ:NVTR)
Earnings by Quarter for Nuvectra Corporation (NASDAQ:NVTR)
Earnings History by Quarter for Nuvectra Corporation (NASDAQ NVTR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/7/2017($1.16)N/AView Earnings Details
8/8/2017Q2 2017($1.14)($1.07)$5.96 million$7.20 millionViewListenView Earnings Details
5/9/2017Q1 2017($1.25)($1.27)$4.61 million$5.00 millionViewListenView Earnings Details
3/7/2017Q4 2016($0.89)($1.27)$3.97 million$4.20 millionViewListenView Earnings Details
11/9/2016Q3 2016($0.88)($0.92)$2.81 million$3.80 millionViewListenView Earnings Details
8/10/2016Q216($1.13)($0.85)$2.40 million$2.50 millionViewListenView Earnings Details
5/11/2016Q1($0.51)($0.70)$2.06 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Nuvectra Corporation (NASDAQ:NVTR)
2017 EPS Consensus Estimate: ($4.54)
2018 EPS Consensus Estimate: ($3.17)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171($1.25)($1.25)($1.25)
Q2 20171($1.24)($1.24)($1.24)
Q3 20171($1.22)($1.22)($1.22)
Q4 20171($0.83)($0.83)($0.83)
Q1 20181($0.84)($0.84)($0.84)
Q2 20181($0.86)($0.86)($0.86)
Q3 20181($0.75)($0.75)($0.75)
Q4 20181($0.72)($0.72)($0.72)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Nuvectra Corporation (NASDAQ:NVTR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Nuvectra Corporation (NASDAQ:NVTR)
Insider Ownership Percentage: 3.60%
Institutional Ownership Percentage: 57.20%
Insider Trades by Quarter for Nuvectra Corporation (NASDAQ:NVTR)
Institutional Ownership by Quarter for Nuvectra Corporation (NASDAQ:NVTR)
Insider Trades by Quarter for Nuvectra Corporation (NASDAQ:NVTR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/11/2017Scott F DreesCEOBuy10,000$11.72$117,200.00View SEC Filing  
5/30/2017Scott F DreesCEOBuy7,395$10.41$76,981.95View SEC Filing  
5/25/2017Scott F DreesCEOBuy2,605$9.92$25,841.60View SEC Filing  
3/16/2017Joseph A MillerDirectorBuy25,000$6.11$152,750.00View SEC Filing  
3/14/2017Scott F DreesCEOBuy25,000$6.21$155,250.00View SEC Filing  
1/4/2017Thomas Kelley HickmanEVPSell133$5.36$712.88View SEC Filing  
5/19/2016David D JohnsonDirectorBuy30,000$14.02$420,600.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Nuvectra Corporation (NASDAQ:NVTR)
Latest Headlines for Nuvectra Corporation (NASDAQ:NVTR)
Source:
DateHeadline
finance.yahoo.com logoETFs with exposure to Nuvectra Corp. : October 17, 2017
finance.yahoo.com - October 18 at 7:48 AM
americanbankingnews.com logo Analysts Anticipate Nuvectra Corporation (NVTR) Will Announce Earnings of -$1.16 Per Share
www.americanbankingnews.com - October 13 at 10:32 AM
finance.yahoo.com logoETFs with exposure to Nuvectra Corp. : October 6, 2017
finance.yahoo.com - October 7 at 6:44 AM
finance.yahoo.com logoNuvectra Corp. :NVTR-US: Earnings Analysis: Q2, 2017 By the Numbers : October 5, 2017
finance.yahoo.com - October 5 at 12:51 PM
americanbankingnews.com logoNuvectra Corporation (NVTR) Expected to Announce Earnings of -$1.16 Per Share
www.americanbankingnews.com - September 24 at 4:20 PM
finance.yahoo.com logoFirst Spinal Cord Stimulator Implant Placed in Northern California by Dr. Goldthwaite Brings Pain Relief and Reduces Opioid Use for Local Injured Veteran
finance.yahoo.com - September 12 at 7:29 AM
finance.yahoo.com logoNuvectra to Participate in Morgan Stanley Global Healthcare Conference
finance.yahoo.com - August 31 at 8:05 AM
seekingalpha.com logoExpect Red-Hot Nuvectra To Continue To Perform Well In The Coming Quarters
seekingalpha.com - August 13 at 12:41 AM
americanbankingnews.com logoNuvectra Corporation (NASDAQ:NVTR) Given Average Recommendation of "Hold" by Analysts
www.americanbankingnews.com - August 12 at 2:58 AM
americanbankingnews.com logoNuvectra Corporation (NVTR) CEO Buys $117,200.00 in Stock
www.americanbankingnews.com - August 11 at 8:50 PM
finance.yahoo.com logoEdited Transcript of NVTR earnings conference call or presentation 8-Aug-17 8:30pm GMT
finance.yahoo.com - August 10 at 6:21 AM
finance.yahoo.com logoNuvectra™ Reports Second Quarter 2017 Financial Results
finance.yahoo.com - August 9 at 5:41 AM
finance.yahoo.com logoETFs with exposure to Nuvectra Corp. : August 8, 2017
finance.yahoo.com - August 9 at 5:41 AM
americanbankingnews.com logoNuvectra Corporation (NVTR) Issues Quarterly Earnings Results, Beats Estimates By $0.07 EPS
www.americanbankingnews.com - August 8 at 8:26 PM
americanbankingnews.com logoNuvectra Corporation (NASDAQ:NVTR) Set to Announce Earnings on Tuesday
www.americanbankingnews.com - August 1 at 10:34 AM
finance.yahoo.com logoNuvectra to Present at the Wedbush PacGrow Healthcare Conference
finance.yahoo.com - July 29 at 5:44 AM
finance.yahoo.com logoNuvectra to Report Second Quarter 2017 Financial Results on August 8, 2017
finance.yahoo.com - July 26 at 5:52 AM
americanbankingnews.com logoNuvectra Corporation (NASDAQ:NVTR) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - July 18 at 1:44 PM
americanbankingnews.com logoAnalyzing Senseonics Holdings (SENS) and Nuvectra Corporation (NVTR)
www.americanbankingnews.com - July 18 at 11:14 AM
americanbankingnews.com logoNuvectra Corporation (NASDAQ:NVTR) and Senseonics Holdings (SENS) Head to Head Analysis
www.americanbankingnews.com - July 15 at 7:42 AM
americanbankingnews.com logoAnalyzing Senseonics Holdings (SENS) & Nuvectra Corporation (NVTR)
www.americanbankingnews.com - July 12 at 6:28 PM
finance.yahoo.com logoETFs with exposure to Nuvectra Corp. : July 10, 2017
finance.yahoo.com - July 11 at 6:12 AM
americanbankingnews.com logoNuvectra Corporation (NVTR) Receives Neutral Rating from Piper Jaffray Companies
www.americanbankingnews.com - July 9 at 8:06 AM
seekingalpha.com logoNuvectra Corporation misses by $0.02, beats on revenue
seekingalpha.com - May 9 at 6:35 PM
nasdaq.com logoNuvectra™ Reports First Quarter 2017 Financial Results
www.nasdaq.com - May 9 at 6:35 PM
streetinsider.com logoNuvectra Corporation (NVTR) Misses Q1 EPS by 2c, Beat on Revenues
www.streetinsider.com - May 9 at 6:35 PM
marketbeat.com logoNuvectra reports 1Q loss
marketbeat.com - May 9 at 5:44 PM
biz.yahoo.com logoNUVECTRA CORP Files SEC form 10-K, Annual Report
biz.yahoo.com - March 9 at 6:46 PM
seekingalpha.com logoNuvectra Corporation (NVTR) Presents At Cowen and Company 37th Annual Health Care Conference
seekingalpha.com - March 8 at 7:42 PM
biz.yahoo.com logoQ4 2016 Nuvectra Corp Earnings Release - Before Market Open
us.rd.yahoo.com - March 7 at 11:47 PM
nasdaq.com logoNuvectra™ Reports Fourth Quarter and Full Year 2016 Financial Results
www.nasdaq.com - March 7 at 10:02 AM
seekingalpha.com logoNuvectra Corporation misses by $0.38, beats on revenue
seekingalpha.com - March 7 at 10:02 AM
biz.yahoo.com logoNUVECTRA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
biz.yahoo.com - March 7 at 10:02 AM
us.rd.yahoo.com logoNuvectra Extends Timeline of Existing Credit Facility
us.rd.yahoo.com - February 14 at 10:12 PM
us.rd.yahoo.com logoNuvectra Files Regulatory Submissions for FDA and CE Mark Approvals of the Virtis™ Sacral Nerve Stimulation (SNS) System
us.rd.yahoo.com - February 1 at 8:04 PM
us.rd.yahoo.com logo10:01 am Nuvectra files regulatory submissions with the FDA and CE Mark authorities for Virtis
us.rd.yahoo.com - February 1 at 8:04 PM
biz.yahoo.com logoNUVECTRA CORP Files SEC form 8-K, Change in Directors or Principal Officers
biz.yahoo.com - January 17 at 7:18 PM
seekingalpha.com logoNuvectra Corporation misses by $0.04, beats on revenue
seekingalpha.com - November 10 at 9:37 AM
biz.yahoo.com logoQ3 2016 Nuvectra Corp Earnings Release - After Market Close
biz.yahoo.com - November 9 at 9:03 AM
seekingalpha.com logoNuvectra: Post Spin-Off
seekingalpha.com - October 5 at 11:45 AM
seekingalpha.com logoAptevo Therapeutics: A Biotech Spinoff With Potential
seekingalpha.com - September 22 at 11:19 AM
streetinsider.com logoPiper Jaffray Cuts Price Target on Nuvectra Corporation (NVTR) Following 2Q Revenue Beat
www.streetinsider.com - August 12 at 9:45 AM
biz.yahoo.com logoQ2 2016 Nuvectra Corp Earnings Release - After Market Close
biz.yahoo.com - August 10 at 9:40 AM
biz.yahoo.com logoNUVECTRA CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
biz.yahoo.com - August 1 at 6:19 PM
biz.yahoo.com logoNUVECTRA CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
biz.yahoo.com - June 17 at 4:32 PM
biz.yahoo.com logoNuvectra Corp Earnings Call scheduled for 4:30 pm ET today
biz.yahoo.com - May 11 at 4:30 PM

Social

Chart

Nuvectra Corporation (NVTR) Chart for Thursday, October, 19, 2017

This page was last updated on 10/19/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.